Speakers at the Institute for Value-Based Medicine event held September 18, 2025, in Nyack, New York, spoke about methods of managing cardio-renal-metabolic disease.
Cambridge: AstraZeneca has announced that its New Drug Application (NDA) for baxdrostat has been accepted for Priority Review ...
If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under 10 ...
Millions in India face chronic kidney disease, with drug-induced damage a significant concern. Common medications like NSAIDs, antibiotics, and contra ...
AstraZeneca’s NDA for baxdrostat accepted under US FDA Priority Review in US for patients with hard-to-control hypertension: Cambridge, UK Wednesday, December 3, 2025, 09:00 Hrs ...
Background Hypertension is a significant risk factor for cardiovascular disease, dementia and chronic kidney disease (CKD).
One-year program includes diet, exercise, stress relief, and physician consultations. Glycemic control and other markers ...
Dr Sumeska Thavarajah emphasizes the importance of staying current with new therapies and adopting a holistic and collaborative approach to patient care.
Our kidneys work around the clock, removing toxins from our body, filtering waste, and purifying the liver. Over time, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback